2-Feb-2026
Cathie Wood's weekly recap: ramps up bets on JOBY, CRSP, pares ILMN, VCYT
Seeking Alpha News (Mon, 2-Feb 7:30 AM ET)
Market Chameleon (Mon, 2-Feb 2:09 AM ET)
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield
Business Wire (Mon, 2-Feb 7:00 AM ET)
Business Wire (Tue, 27-Jan 8:30 AM ET)
Tempus Announces the Launch of Paige Predict
Business Wire (Wed, 21-Jan 8:30 AM ET)
Tempus Collaboration Expands Access to Genomic Testing for Northwestern Medicine Cancer Patients
Market Chameleon (Mon, 12-Jan 6:19 AM ET)
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
Business Wire (Mon, 12-Jan 8:30 AM ET)
Northwestern Medicine Selects Tempus to Expand Genomic Testing
Business Wire (Mon, 12-Jan 7:00 AM ET)
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
Business Wire (Sun, 11-Jan 5:30 PM ET)
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
Business Wire (Sun, 11-Jan 5:00 PM ET)
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Tempus Ai - Class A trades on the NASDAQ stock market under the symbol TEM.
As of February 2, 2026, TEM stock price declined to $58.55 with 4,781,559 million shares trading.
TEM has a beta of 2.11, meaning it tends to be more sensitive to market movements. TEM has a correlation of 0.19 to the broad based SPY ETF.
TEM has a market cap of $10.17 billion. This is considered a Large Cap stock.
Last quarter Tempus Ai - Class A reported $334 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.14.
The top ETF exchange traded funds that TEM belongs to (by Net Assets): ARKK, VTI, VB, ARKG, VBK.
TEM has underperformed the market in the last year with a price return of +2.0% while the SPY ETF gained +16.8%. TEM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -34.8% and -16.7%, respectively, while the SPY returned +2.2% and +0.5%, respectively.
TEM support price is $57.02 and resistance is $62.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TEM shares will trade within this expected range on the day.